Show simple item record

dc.contributor.authorPidsley, R
dc.contributor.authorViana, Joana
dc.contributor.authorHannon, E
dc.contributor.authorSpiers, Helen
dc.contributor.authorTroakes, C
dc.contributor.authorAl-Saraj, Safa
dc.contributor.authorMechawar, Naguib
dc.contributor.authorTurecki, Gustavo
dc.contributor.authorSchalkwyk, Leonard
dc.contributor.authorBray, Nicholas J.
dc.contributor.authorMill, J
dc.date.accessioned2016-02-05T11:59:57Z
dc.date.issued2014-10-28
dc.description.abstractBACKGROUND: Schizophrenia is a severe neuropsychiatric disorder that is hypothesized to result from disturbances ine arly brain development. There is mounting evidence to support a role for developmentally regulated epigenetic variation in the molecular etiology of the disorder. Here, we describe a systematic study of schizophrenia-associated methylomic variation in the adult brain and its relationship to changes in DNA methylation across human fetal brain development. RESULTS: We profile methylomic variation in matched prefrontal cortex and cerebellum brain tissue from schizophrenia patients and controls, identifying disease-associated differential DNA methylation at multiple loci,particularly in the prefrontal cortex, and confirming these differences in an independent set of adult brain samples.Our data reveal discrete modules of co-methylated loci associated with schizophrenia that are enriched for genes involved in neurodevelopmental processes and include loci implicated by genetic studies of the disorder. Methylomic data from human fetal cortex samples, spanning 23 to 184 days post-conception, indicates that schizophrenia-associated differentially methylated positions are significantly enriched for loci at which DNA methylation is dynamically altered during human fetal brain development. CONCLUSIONS: Our data support the hypothesis that schizophrenia has an important early neurodevelopmental component, and suggest that epigenetic mechanisms may mediate these effects.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipUS National Institutes of Healthen_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.identifier.citationVol. 15, article 483en_GB
dc.identifier.doi10.1186/s13059-014-0483-2
dc.identifier.grantnumberMR/K013807/1en_GB
dc.identifier.grantnumberAG036039en_GB
dc.identifier.grantnumberG0700089en_GB
dc.identifier.grantnumberGR082557en_GB
dc.identifier.urihttp://hdl.handle.net/10871/19625
dc.language.isoenen_GB
dc.publisherBioMed Centralen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/25347937en_GB
dc.rights© 2014 Pidsley et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en_GB
dc.subjectBrainen_GB
dc.subjectCerebellumen_GB
dc.subjectDNA Methylationen_GB
dc.subjectEpigenesis, Geneticen_GB
dc.subjectFetal Developmenten_GB
dc.subjectHumansen_GB
dc.subjectPrefrontal Cortexen_GB
dc.subjectSchizophreniaen_GB
dc.titleMethylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophreniaen_GB
dc.typeArticleen_GB
dc.date.available2016-02-05T11:59:57Z
dc.identifier.issn1465-6906
exeter.place-of-publicationEngland
dc.identifier.journalGenome Biologyen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record